Accenture, a professional service company specializing in information technology and consulting, acquired Bionest, a strategic consulting firm providing strategic decision-supporting services for companies in biopharma, precision medicine, diagnostics, oncology, cell & gene therapy (CGT), and rare diseases.
Terms of the transaction were not disclosed.
As part of the acquisition, Bionest’s team of 46 consultants, industry executives, and specialists will join Accenture Strategy in the Life Sciences practice business unit.
Commenting on the acquisition news, Brad Michel, a senior managing director at Accenture who leads its North America Life Sciences practice, said, “Biopharma companies are shifting to New Science to drive more precise and effective ways to treat and care for patients in previously unattainable ways. Oncology, precision medicine, and cell and gene therapies will drive disproportionate growth while delivering differentiated patient outcomes in the coming years.”
“The addition of Bionest’s highly skilled team of experts expands our capabilities and will support our clients in bringing therapeutics to patients faster and more efficiently,” added Brad Michel.
Melinda Kutzing, Bionest leader and managing director, added, “By joining Accenture, we’ll be able to bring new capabilities to our clients through strategy development and operational execution in some of the most exciting areas of science.” Bionest’s clients include both major established and emerging pharmaceutical and biotechnology brands, chiefly in North America and Europe.
According to our M&A database, more than 200 digital health consulting startups have been acquired to date. More recently, Nordic Consulting, a global healthcare technology consulting company, acquired Hygeian, a healthcare management and technology consulting service provider, for an undisclosed amount. In another deal, Alira Health, a patient-centric global healthcare advisory company, acquired Artisan Healthcare Consulting, a management consulting firm that provides strategic insights to healthcare product companies.